
    
      This is an open label study. Initially, 5 patients with DME will receive an ITV injection of
      VEGF Trap into the study eye. Additional patients may be enrolled at the same or additional
      dose levels. Patients will be observed for six weeks following the injection for assessments
      of ocular and systemic safety.
    
  